miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway

INTRODUCTION: Prostate cancer (PCa) is one of the most common malignancies, and almost all patients with advanced PCa will develop castration-resistant prostate cancer (CRPC) after receiving endocrine therapy. Effective treatment for patients with CRPC has not been established. Novel approaches are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jiafu, Xu, Houqiang, Duan, Zhiqiang, Chen, Xiang, Ao, Zheng, Chen, Yinglian, Ruan, Yong, Ni, Mengmeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402864/
https://www.ncbi.nlm.nih.gov/pubmed/32801901
http://dx.doi.org/10.2147/CMAR.S247780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402864/
https://www.ncbi.nlm.nih.gov/pubmed/32801901
http://dx.doi.org/10.2147/CMAR.S247780

Ejemplares similares